Aurobindo Pharma receives two new registration from MCC - South Africa
Aurobindo Pharma Ltd is pleased to announce that Medicines Control Council (MCC) South Africa has granted approval to manufacture and market two more products in South Africa.
The products approved are as follows: - Product Name: AURO-AMPICILLIN 500mg and 1000mg Dosage Form : Injection Active Ingredient: Ampicllin Sodium Category: Anti-infective
- Product Name: AUROPIDONE 0.5mg Dosage Form : Tablet Active Ingredient: Risperidone Category: CNS
Aurobindo now has a total of 37 products approved by the MCC.
The stock was trading at Rs.811, down by Rs.7.80 or 0.95%. The stock hit an intraday high of Rs.818 and low of Rs.781.
The total traded quantity was 8018 compared to 2 week average of 16241.
